A detailed history of Cascade Investment Group, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Cascade Investment Group, Inc. holds 5,535 shares of EW stock, worth $511,267. This represents 0.4% of its overall portfolio holdings.

Number of Shares
5,535
Previous 6,035 8.29%
Holding current value
$511,267
Previous $460 Million 14.94%
% of portfolio
0.4%
Previous 0.37%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $36,270 - $47,780
-500 Reduced 8.29%
5,535 $529 Million
Q4 2023

Jan 16, 2024

BUY
$61.71 - $77.76 $18,513 - $23,328
300 Added 5.23%
6,035 $460 Million
Q2 2023

Jul 19, 2023

SELL
$81.41 - $94.33 $1,628 - $1,886
-20 Reduced 0.35%
5,735 $541 Million
Q4 2022

Feb 27, 2023

BUY
$68.3 - $87.44 $393,066 - $503,217
5,755 New
5,755 $429 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Cascade Investment Group, Inc. Portfolio

Follow Cascade Investment Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cascade Investment Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cascade Investment Group, Inc. with notifications on news.